Results 141 to 150 of about 58,766 (263)

Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus‐Associated Disorders

open access: yesCancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Kaposi sarcoma herpes virus (KSHV) is associated with multiple clinical manifestations, including primary effusion lymphoma, an aggressive CD38+ B cell lymphoma with a plasmablastic phenotype. Case This case describes an antiretroviral therapy‐adherent person with HIV who presented with concurrent KSHV‐related disorders of Kaposi ...
Kandice Roberts   +13 more
wiley   +1 more source

Cytologic Findings in Esophageal Perforation: An Institutional Experience With Pleural Fluid Specimens

open access: yesDiagnostic Cytopathology, Volume 54, Issue 6, Page 429-435, June 2026.
ABSTRACT Introduction Esophageal perforation (EP) is a rare but life‐threatening condition, and most cases are due to iatrogenic causes. The rest occur spontaneously, due to malignancies, or trauma. The mortality rates can approach 50%, and delayed diagnosis of EP exacerbates patient outcomes.
Mason Marshall   +3 more
wiley   +1 more source

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced‐stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study

open access: yesHemaSphere, Volume 10, Issue 6, June 2026.
Abstract Follicular lymphoma (FL) is the most common indolent lymphoma. Although chemoimmunotherapy is effective, toxicity remains problematic, and novel treatments are required. We performed a Phase Ib/II study of obinutuzumab, lenalidomide, and venetoclax in patients with treatment‐naïve, high tumor burden, advanced‐stage FL. During induction (6 × 28‐
Chan Y. Cheah   +11 more
wiley   +1 more source

Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis‐endemic setting

open access: yesHemaSphere, Volume 10, Issue 6, June 2026.
Abstract In HIV‐ and tuberculosis (TB)‐endemic regions, lymphoma diagnosis is often delayed because symptoms can overlap with TB, and access to biopsy and specialized pathology is limited. To address this, we developed and internally evaluated the Access to Diagnosis using Liquid Biopsy (ADLiB) platform—a plasma cell‐free DNA (cfDNA)‐based approach ...
Katherine Antel   +21 more
wiley   +1 more source

The palliation of malignant pleural effusions

open access: yesBritish Journal of Hospital Medicine, 2012
Bhatnagar, Rahul, Rahman, Najib M
openaire   +2 more sources

Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum‐resistant ovarian cancer: Phase I expansion results

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 173, Issue 3, Page 1334-1342, June 2026.
Abstract Objective In the dose‐escalation part of Study 101, which included multiple tumor types, objective responses were observed in 10 of 22 patients across multiple dose levels of farletuzumab ecteribulin (FZEC). We explored the safety/antitumor activity of FZEC in patients with platinum‐resistant ovarian cancer (PROC) from the Study 101 expansion ...
Kan Yonemori   +11 more
wiley   +1 more source

First line medical thoracoscopy in undiagnosed pleural effusion.

open access: yes
reservedBackground: il versamento pleurico non spiegato rimane un frequente problema clinico. Le attuali linee guida internazionali descrivono un percorso diagnostico standard in cui la toracoscopia medica viene considerata dopo una fase iniziale di ...
CAPPOZZO, MARCO
core  

Gas Biopsy of Pleural Effusion to Diagnose Lung Cancer by Mass Spectrometry

open access: yesMedComm, Volume 7, Issue 6, June 2026.
HS‐SPME–GC–MS profiling of pleural effusion revealed distinct volatile metabolic features between lung cancer‐associated malignant pleural effusion and benign pleural effusion. Cross‐matrix integration with paired lung cancer tissues identified hexanal as the only shared differential VOC.
Wenting Liu   +10 more
wiley   +1 more source

Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2

open access: yesRespirology Case Reports, Volume 14, Issue 6, June 2026.
We describe a very elderly patient with ECOG performance status 2 who initially declined systemic therapy because of concerns about adverse events but later achieved symptom improvement and sustained disease control with reduced‐dose dabrafenib and trametinib.
Shun Suyama   +5 more
wiley   +1 more source

Pulmonary Sarcoidosis Associated With Pleural Effusion: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 6, June 2026.
A rare case of pulmonary sarcoidosis presenting with bilateral pleural effusion is described in a young adult. Diagnosis was supported by characteristic radiological findings, lymphocyte‐predominant exudative pleural effusion and histological confirmation of non‐caseating granulomas via EBUS‐TBNA.
Shpëtim Thaçi   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy